Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Company price
0.02 AUD 0.00 ( 5.26%)
Last update at 2026-11-12T04:10:00Z
VOLUME
573890
Market Cap
27.42M

Momentum Score

…

dorsaVi Ltd develops and sells motion analysis technologies in Australia, Europe, and the United States. It operates through three segments: Clinical, Workplace, and RRAM. The company provides ViMove+, a clinical and sports solutions; VideoAI, a visual movement data; ViSafe+, a measure movement, identify risk, and support proactive safety programs; and Research+, a precision tools for movement research. It serves clinic and sports, workplace, and research industries. dorsaVi Ltd was incorporated in 2008 and is based in Oakleigh South, Australia.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.02
Low
0.02
High
52 Week Price Range
0.02
Low
0.06
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Dorsavi Ltd develops wearable sensor systems and cloud analytics that quantify human movement and muscle activity for clinical, sports and workplace health applications. Long-term growth may be supported by rising demand for remote monitoring, workplace injury prevention and recurring software subscriptions as adoption broadens across healthcare providers and employers. The company appears positioned to benefit from growing interest in objective mobility metrics and data-driven injury-reduction programs.

Key investment risks include competitive pressure and technology commoditisation, slower-than-expected adoption or reimbursement, execution and international expansion challenges, and potential need for additional capital to fund growth.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.02
Dividend Yield
-
Revenue TTM
1.00M
Revenue Per Share
0.00
Gross Profit TTM
0.71M
Debt / Equity
0.02
ROE
-237.75%
Net Debt
-2.06M
ROCE
-171.63%
Diluted EPS TTM
-0.01

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Income before tax -8.97M -1.87M -1.70M -2.31M -2.10M
Net income -8.52M -1.52M -1.25M -1.82M -1.54M
Selling general administrative - 0.97M 1.43M 2.12M 3.08M
Selling and marketing expenses - 0.07M 0.06M 0.18M 0.20M
Gross profit -3.33M 0.97M 1.18M 1.58M 2.52M
Reconciled depreciation - - 0.08M 0.18M 0.18M
Ebit -7.48M -1.88M -1.68M -2.07M -1.71M
Ebitda -7.36M -1.82M -1.60M -1.88M -1.53M
Depreciation and amortization 0.12M 0.06M 0.08M 0.18M 0.18M
Operating income -7.48M -1.88M -1.69M -2.30M -2.68M
Other operating expenses 8.48M 3.63M 3.00M 3.33M 3.51M
Interest expense 0.01M 0.01M 0.02M 0.24M 0.39M
Tax provision - -0.36M -0.46M -0.49M -0.56M
Interest income - 0.01M 0.01M 0.24M 0.39M
Net interest income - - -0.01M -0.24M -0.39M
Income tax expense -0.45M 0.36M -0.46M -0.49M -0.56M
Total revenue 1.00M 1.13M 1.30M 1.83M 2.80M
Total operating expenses 4.15M 3.47M 3.64M 3.87M 4.90M
Cost of revenue 4.33M 0.16M 0.12M 0.25M 0.28M
Total other income expense net -1.49M 0.01M -0.01M 0.22M 0.67M
Net income from continuing ops - - -1.25M -1.82M -1.54M
Net income applicable to common shares - -1.52M -1.25M -1.82M -1.54M
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Total assets 5.85M 3.97M 2.18M 2.69M 3.36M
Intangible assets 1.49M 0.32M - - -
Other current assets 1.07M 0.52M 0.13M 0.18M 0.72M
Total liab 1.51M 1.14M 1.16M 1.01M 2.13M
Total stockholder equity 4.34M 2.84M 1.02M 1.68M 1.22M
Other current liab 0.61M 0.71M 0.45M 0.37M 1.48M
Common stock 58.91M 50.58M 47.29M 46.33M 44.53M
Capital stock - - - 46.33M 44.53M
Retained earnings -56.17M -47.84M -46.53M -45.28M -43.71M
Other liab - - - 0.01M 0.00M
Other assets - - 0.00M - 0.00M
Cash 2.12M 2.29M 0.48M 0.88M 0.45M
Cash and equivalents - - - - 0.45M
Total current liabilities 1.49M 1.06M 1.05M 0.98M 2.07M
Current deferred revenue 0.27M - 0.38M 0.27M 0.38M
Net debt -2.06M -2.14M -0.29M -0.56M -0.26M
Short term debt 0.05M 0.09M 0.09M 0.30M 0.13M
Short long term debt - - - 0.26M 1.08M
Short long term debt total 0.07M 0.16M 0.19M 0.32M 0.19M
Other stockholder equity - - - -1.04M -0.83M
Property plant equipment - - - 0.16M 0.29M
Total current assets 4.26M 3.51M 1.96M 2.53M 3.07M
Net tangible assets - - - 1.68M 1.22M
Net receivables 0.71M 0.26M 0.86M 0.95M 0.49M
Long term debt - - - - 0.00M
Inventory 0.36M 0.43M 0.49M 0.53M 0.52M
Accounts payable 0.55M 0.27M 0.13M 0.04M 0.08M
Accumulated other comprehensive income 1.60M 0.09M 0.27M 0.64M 0.40M
Non currrent assets other - - 0.02M -0.16M -0.29M
Non current assets total 1.59M 0.47M 0.22M 0.16M 0.29M
Capital lease obligations - - - 0.06M 0.10M
Long term debt total - - - - 0.06M
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Investments - - -0.02M -0.05M -0.10M
Change to liabilities - - - -0.02M -0.46M
Total cashflows from investing activities -0.01M -0.30M -0.02M -0.05M -0.10M
Net borrowings - - -0.20M 0.12M -0.09M
Total cash from financing activities 5.12M 3.08M 0.23M 1.45M -0.09M
Change to operating activities - - - 0.14M -0.20M
Net income -8.52M -1.52M -1.25M -1.82M -1.54M
Change in cash -0.17M 1.82M -0.40M 0.43M -2.35M
Begin period cash flow 2.29M 0.48M 0.88M 0.45M 2.80M
End period cash flow 2.12M 2.29M 0.48M 0.88M 0.45M
Total cash from operating activities -5.28M -0.96M -0.60M -0.97M -2.15M
Issuance of capital stock - - 0.50M 1.45M -
Depreciation 0.12M 0.06M 0.08M 0.18M 0.18M
Other cashflows from investing activities - -0.30M -0.02M - -
Dividends paid - - - 0.30M 1.33M
Change to inventory 0.07M - 0.04M -0.00M 0.10M
Change to account receivables -0.05M - 0.08M 0.21M 0.21M
Sale purchase of stock - 3.38M -0.03M -0.12M -0.12M
Other cashflows from financing activities -0.04M -0.26M -0.04M 0.56M 0.01M
Change to netincome - - - 0.34M -0.46M
Capital expenditures 0.00M 0.00M 0.02M 0.05M 0.10M
Change in working capital -0.71M 0.02M 0.41M 0.20M 0.32M
Stock based compensation - 0.00M - 0.43M 0.27M
Other non cash items 3.84M 0.50M 0.15M 0.67M -0.80M
Free cash flow -5.28M -0.96M -0.62M -1.02M -2.25M

Peer Comparison*

Sector: Technology Industry: Scientific & Technical Instruments

Stock Name
Change
(AUD)
Price
(AUD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
DVL
Dorsavi Ltd
0.00
5.26%
0.02 - 3.27 27.31 6.32 25.27 -5.11
CDA
Codan Ltd
-1.83
3.16%
56.07 58.46 36.76 11.69 17.92 12.47 38.25
CAT
Catapult Group International Ltd
-0.05
1.31%
3.76 - 49.02 8.40 3.56 5.03 46.83
OIL
Optiscan Imaging Ltd
0.00
1.29%
0.16 - 10.82 44.85 8.28 320.51 -12.11
IKE
Ikegps Group Ltd
-
-%
0.70 - - 4.96 6.72 5.61 -3.62

Profile*

Dorsavi Ltd

dorsaVi Ltd develops and sells motion analysis technologies in Australia, Europe, and the United States. It operates through three segments: Clinical, Workplace, and RRAM. The company provides ViMove+, a clinical and sports solutions; VideoAI, a visual movement data; ViSafe+, a measure movement, identify risk, and support proactive safety programs; and Research+, a precision tools for movement research. It serves clinic and sports, workplace, and research industries. dorsaVi Ltd was incorporated in 2008 and is based in Oakleigh South, Australia.

11-13 Milgate Street, Oakleigh South, VIC, Australia, 3167

61 3 1800 367 728

Name Title Year Born
Dr. Andrew James Ronchi B.App.Sci., GAICD, Ph.D. Co-Founder, MD, CEO & Exec. Director NA
Mr. Troy Di Domenico Chief Financial Officer NA
Mr. Daniel Mathew Ronchi Ass.Deg.Law Chief Technology Officer NA
Ms. Joanna Goldin Clinical Mang. NA
Mr. Brendan T. Case BEc, C.P.A., CPA, Dip FP, FCIS, Grad Dip., MComLaw Company Sec. NA
Dr. Andrew James Ronchi B.App.Sci., GAICD, Ph.D. Co-Founder, MD, CEO & Executive Director NA
Mr. Aaron Chan Chief Financial Officer NA
Mr. Justin Mouchacca B.Bus (Acc), C.A., CA Company Secretary NA
Dr. Andrew James Ronchi B.App.Sci., GAICD, Ph.D. Co-Founder, MD, CEO & Executive Director NA
Mr. Aaron Chan Chief Financial Officer NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…